Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-17-007724
Filing Date
2017-08-09
Accepted
2017-08-09 06:02:01
Documents
6
Period of Report
2017-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp79347_6k.htm 6-K 13258
2 EXHIBIT 99.1 dp79347_9901.htm EX-99.1 159463
3 EXHIBIT 99.2 dp79347_9902.htm EX-99.2 135405
4 EXHIBIT 99.3 dp79347_9903.htm EX-99.3 60097
5 GRAPHIC image_001.jpg GRAPHIC 12706
6 GRAPHIC image_002.jpg GRAPHIC 10815
  Complete submission text file 0000950103-17-007724.txt   401892
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 171016300
SIC: 2834 Pharmaceutical Preparations